Cti Biopharma Corp

MORGAN STANLEY

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

716,710

Value ($000)

3,010

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	3,010	0.0%	716,710	3/31/2023
2022 Q4	2/14/2023	3,875	0.0%	644,791	12/31/2022
2022 Q3	11/14/2022	4,225	0.0%	726,105	9/30/2022
2022 Q2	10/27/2022	5,200	0.0%	871,096	6/30/2022
2022 Q1	10/27/2022	338	0.0%	72,251	3/31/2022
2021 Q4	2/14/2022	247	0.0%	99,540	12/31/2021
2021 Q3	11/15/2021	1,641	0.0%	556,477	9/30/2021
2021 Q2	8/23/2021	2,664	0.0%	1,065,781	6/30/2021
2021 Q1	5/17/2021	4,272	0.0%	1,467,994	3/31/2021
2020 Q4	2/16/2021	1,220	0.0%	378,780	12/31/2020
2020 Q3	11/13/2020	9	0.0%	4,259	9/30/2020
2020 Q2	8/14/2020	2	0.0%	1,929	6/30/2020
2020 Q1	5/26/2020	4	0.0%	4,398	3/31/2020
2019 Q4	2/14/2020	26	0.0%	16,568	12/31/2019